Statin therapy prevents expansive remodeling in venous bypass grafts

Atherosclerosis

Volumn 223, Issue 1, 2012, Pages 106-113

  Qiang, Beiping ^a   Toma, Jonathan ^a   Fujii, Hiroko ^b   Osherov, Azriel B ^a   Nili, Nafiseh ^a   Sparkes, John D ^a   Fefer, Paul ^a   Samuel, Michelle ^a   Butany, Jagdish ^c   Leong Poi, Howard ^b   Strauss, Bradley H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Expansive positive remodeling; Intimal hyperplasia; Matrix metalloproteinase; Saphenous vein grafts

Indexed keywords

ATORVASTATIN; CHOLESTEROL; GELATINASE A; MACROPHAGE ELASTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GRAFT FAILURE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TREATMENT FAILURE; VEIN GRAFT;

ANASTOMOSIS, SURGICAL; ANIMALS; BIOLOGICAL MARKERS; CAROTID ARTERY, COMMON; CELL PROLIFERATION; CHOLESTEROL, DIETARY; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; JUGULAR VEINS; MACROPHAGES; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 2; MODELS, ANIMAL; NEOINTIMA; PYRROLES; RABBITS; TIME FACTORS; VASCULAR GRAFTING;

EID: 84863101219     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.03.013     Document Type: Article

References (31)

1. DeFrances CJ, Lucas CA, Buie VC et al., 2006 National Hospital Discharge Survey. National Health Statistics Reports 2008. Available at: http://www.cdc.gov/nchs/data/nhsr/.
2. Epstein A.J., Polsky D., Yang F., et al. Coronary revascularization trends in the United States, 2001-2008. JAMA 2011, 305:1769-1776.
3. Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 1999, 100:1464-1480.
4. Goldman S., Zadina K., Moritz T., et al. VA Cooperative Study Group #207/297/364 long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a department of veterans affairs cooperative study. Journal of the American College of Cardiology 2004, 44:2149-2156.
5. Collins P., Webb C.M., Chong C.F., et al. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up. Circulation 2008, 117:2859-2864.
6. Fitzgibbon G.M., Kafka H.P., Leach A.J., et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. Journal of the American College of Cardiology 1996, 28:616-626.
7. Morwani J.G., Topol E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998, 97:916-931.
8. Parang P., Arora R. Coronary vein graft disease: pathogenesis and prevention. Canadian Journal of Cardiology 2009, 25:e57-e62.
9. Kalra M., Miller V.M. Early remodeling of saphenous vein grafts: proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow. The Journal of Vascular Research 2000, 37:576-584.
10. Wong A.P., Jackson Z.S., Nili N., et al. Positive remodeling in venous bypass grafts: novel implications for vein graft disease. Atherosclerosis 2008, 196:580-589.
11. Maehara A., Mintz G.S., Bui A.B., et al. Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. Journal of the American College of Cardiology 2002, 40:904-910.
12. Campeau L., Enjalbert M., Lespérance J., et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation: a study 10 years after aortocoronary bypass surgery. The New England Journal of Medicine 1984, 311:1329-1332.
13. White C.W., Gobel F.L., Campeau L., et al. Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial. Circulation 2001, 104:2660-2665.
14. The post coronary artery bypass graft trial investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary bypass grafts. The New England Journal of Medicine 1997; 336:153-62.
15. Luan Z., Chase A.J., Newby A.C. Statins inhibit secretion of metalloproteinases-1, -2 -3, and -9 from vascular smooth muscle cells and macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology 2003, 23:769-775.
16. Turner N.A., O'Regan D.J., Ball S.G., et al. Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels. The FASEB Journal 2005, 19:804-806.
17. Rashid S., Uffelman K.D., Barrett P.H., et al. Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbit. Circulation 2002, 106:2955-2960.
18. Gill R.W. Measurement of blood flow by ultrasound: accuracy and sources of error. Ultrasound in Medicine and Biology 1985, 11:625-641.
19. Li C., Cantor W.J., Nili N., et al. Arterial repair after stenting and the effect of GM6001, a matrix metalloproteinase inhibitor. Journal of the American College of Cardiology 2002, 39:1852-1858.
20. Larsen P.H., Yong V.W. The expression of matrix metalloproteinase-12 by oligodendrocytes regulates their maturation and morphological differentiation. The Journal of Neuroscience 2004, 24:7597-7603.
21. Yamanouchi D., Banno H., Nakayama M., et al. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition. Journal of Vascular Surgery 2005, 42:757-764.
22. Fujita H., Banno H., Yamanouchi D., et al. Pitavastatin inhibits intimal hyperplasia in rabbit vein graft. Journal of Surgical Research 2008, 148:238-243.
23. Yucel S., Bahcivan M., Gol M.K., et al. Reduced intimal hyperplasia in rabbits via medical therapy after carotid venous bypass. Texas Heart Institute Journal 2009, 36:387-392.
24. Stancu C., Sima A. Statins: mechanism of action and effects. Journal of Cellular and Molecular Medicine 2001, 5:378-387.
25. Liao J.K., Laufs U. Pleiotropic effects of statins. The Annual Review of Pharmacology and Toxicology 2005, 45:89-118.
26. Wyatt A.P., Gonzales I.E. Atheromatous lesions in arterialized vein grafts: an experimental study. British Journal of Surgery 1969, 56193-56199.
27. Zwolak R.M., Kirkman T.R., Clowes A.W. Atherosclerosis in rabbit vein. Arteriosclerosis 1989, 9:374-379.
28. Iiyama K., Hajra L., Iiyama M., et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circulation Research 1999, 85:199-207.
29. Hanyu M., Kume N., Ikeda T., et al. VCAM-1 expression precedes macrophage infiltration into subendothelium of vein grafts interposed into carotid arteries in hypercholesterolemic rabbits-a potential role in vein graft atherosclerosis. Atherosclerosis 2001, 158:313-319.
30. Nachtigal P., Pospisilova N., Jamborova G., et al. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice. Life Sciences 2008, 82:708-717.
31. Mannello F., Raffetto J.D. Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research. American Journal of Translational Research 2011, 3:149-158.